Literature DB >> 23389595

Amgen deal triggers watchful waiting in targeted nanomedicine.

Monica Heger.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23389595     DOI： 10.1038/nm0213-120b

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  A new approach to reduce toxicities and to improve bioavailabilities of platinum-containing anti-cancer nanodrugs.

Authors:  Li Liu; Qing Ye; Maggie Lu; Ya-Chin Lo; Yuan-Hung Hsu; Ming-Cheng Wei; Yu-Hsiang Chen; Shen-Chuan Lo; Shian-Jy Wang; Daniel J Bain; Chien Ho
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

2.  Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists.

Authors:  Gopalakrishna Pillai; Maria L Ceballos-Coronel
Journal:  SAGE Open Med       Date:  2013-11-23

Review 3.  Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas.

Authors:  Jaewan Jeon; Sungmin Lee; Hyunwoo Kim; Hyunkoo Kang; HyeSook Youn; Sunmi Jo; BuHyun Youn; Hae Yu Kim
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.